REFERENCES
- Gordon A J, Liberto J, Granda S, et al. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration. Am J Addict 2008; 17: 459–462
- O'Connor P G, Fiellin D A. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med 2000; 133: 40–54
- Fiellin D A, Rosenheck R A, Kosten T R. Office-based treatment for opioid dependence: reaching new patient populations. Am J Psychiatry 2001; 158: 1200–1204
- Fiellin D A, O'Connor P G. Office-based treatment of opioid dependent patients. N Engl J Med 2002; 347: 339–345
- Institute of Medicine. Improving the quality of healthcare for mental and substance-use conditions: The quality chasm series. The National Academies Press, Washington, D. C. 2005
- Gordon A J, Sullivan L E, Alford D P, et al. Update in addiction medicine for the generalist. J Gen Intern Med 2007; 22: 1190–1194
- Gordon A J, Fiellin D A, Friedmann P D, et al. Update in addiction medicine for the primary care clinician. J Gen Intern Med 2008; 23: 2112–2116
- Rogers E M. Diffusion of innovations, 5th ed. Free Press, New York 2003
- Walley A Y, Alperen J K, Cheng D M, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med 2008; 23: 1393–1398
- Fiellin D A, Pantalon M V, Chawarski M C, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006; 355: 365–374
- Fudala P J, Bridge T P, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003; 349: 949–958
- Stein M D, Cioe P, Friedmann P D. Buprenorphine retention in primary care. J Gen Intern Med 2005; 20: 1038–1041
- Goodman F, Gordon A, Kivlahan D, et al. Criteria for non-formulary use of buprenophine sublingual tablets for opioid dependence, criteria for use monograph, Available at: http://www.pbm.va.gov/archive/Buprenorphine.pdf Accessed January 26, 2009
- Goodman F, Gordon A, Kivlahan D, et al. Criteria for use of buprenophine/naloxone and Buprenorphine sublingual tablets, Available at: http://www.pbm.va.gov/criteria/BuprenorphineCriteriaForUse.pdf Accessed January 26, 2009
- Department of Veterans Affairs VHA. Uniform mental health services in VA medical centers and clinics, Available at: http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=1762 Accessed March 23, 2009
- Gordon A J, Trafton J A, Saxon A J, et al. Implementation of buprenorphine in the Veterans Health Administration: Results of the first 3 years. Drug Alcohol Depend 2007; 90: 292–296